olaparib,177lu-psma-617
novartis,astrazeneca,merck
['crpc']
a new strategy for mcrpc is arriving combining 177lu-psma + parpinh is feasible! #asco23 
Medical Oncologist. Involved in GU tumors research. Adjunct Assoc. Professor UCM. Executive member SOGUG Foundation. Hospital Univ. 12 de Octubre. Madrid.